APA
Porter C. J. H., Kaukonen A. M., Taillardat-Bertschinger A., Boyd B. J., O'Connor J. M., Edwards G. A. & Charman W. N. (20041208). Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. : Journal of pharmaceutical sciences.
Chicago
Porter Christopher J H, Kaukonen Ann Marie, Taillardat-Bertschinger Agnes, Boyd Ben J, O'Connor Jacquelyn M, Edwards Glenn A and Charman William N. 20041208. Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. : Journal of pharmaceutical sciences.
Harvard
Porter C. J. H., Kaukonen A. M., Taillardat-Bertschinger A., Boyd B. J., O'Connor J. M., Edwards G. A. and Charman W. N. (20041208). Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. : Journal of pharmaceutical sciences.
MLA
Porter Christopher J H, Kaukonen Ann Marie, Taillardat-Bertschinger Agnes, Boyd Ben J, O'Connor Jacquelyn M, Edwards Glenn A and Charman William N. Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. : Journal of pharmaceutical sciences. 20041208.